Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES INCLUDING CLINICAL, BIOMARKER, IMAGING, QOL, FUNCTIONAL AND LUNG FUNCTI | RIGEL PHARMACEUTICALS INC | $749,999 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN15HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT | Apr 20, 2023 | May 1, 2023 | Oct 31, 2025 |